Lewes, DE -- (SBWIRE) -- 07/23/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Pervasip Corp (OTCMKTS:PVSP), Entest BioMedical Inc. (OTCMKTS:ENTB), Cereplast Inc (OTCMKTS:CERP), Stakool Inc (OTCMKTS:STKO)
Pervasip Corp (OTCMKTS:PVSP) declined -13.16% recently, while trading on 7.59M shares, at the price of $0.0033. The stock changed hands in a range of $0.003 to $0.0042 up till now, bringing its market capitalization at about $1.45M. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.0013 and was moved to the maximum level of $0.017. Pervasip Corp. is a provider of video and voice over Internet Protocol (VoIP), telephony services. The nature of the Company’s technology is cloud-based computing. It sells its video and voice over Internet Protocol VoIP telephony product on a wholesale and retail basis to telephone carriers, broadband suppliers, individual corporations and consumers.
Has PVSP Found The Bottom and Ready To Move Up? Find Out Here
Entest BioMedical Inc. (OTCMKTS:ENTB) added 23.08% recently, in the current trading session, at $0.0016 with a total volume of 9.34M shares. The stock, on average, trades on a volume of 8.37M shares. It floated in a range of $0.0012 to $0.0017 during the recent trading session, with a beta value of 41.97. Its market capitalization now moved to about $714,432.00. In the past 52 weeks, the share price has not declined below $0.0001 or above $0.0106. Entest BioMedical, Inc. (Entest) is a development-stage company. During the fiscal year ended August 31, 2012, the Company’s business consists of the development and commercialization of immunotherapeutic therapies for the veterinary market, as well as the acquisition and operation of veterinary hospitals.
For How Long ENTB Gloss will Attract Investors? Find out via this report
Cereplast Inc (OTCMKTS:CERP) recently recorded a gain of 12.67% and was moving within a range of $0.01 -$0.02, its current trading price is $0.0169. The stock is moving up till now with a total volume of 8.37M shares, versus an average volume of 10.74M shares. The share price hit its 52-week low of $0.01 on Jan 22, 2013 and $0.47 was the best price in the same period. Cereplast, Inc. (Cereplast) is engaged in developing and commercializing bio-based resins through two product families: Cereplast Compostables Resins, which are compostable, renewable, ecologically sound substitutes for petroleum-based plastics.
Will CERP Continue To Move Higher? Find Out Here
Stakool Inc (OTCMKTS:STKO) added 100.00% in its current trading activity, bringing its market capitalization around $701,778.00. The share price, after opening at $0.0001, hit a high of $0.0002 and hovered above $0.0001, while its recent trading price was $0.0002. The total number of shares changed hands during the current session up till now was 9.00M shares, as compared to average trading volume of 57.24M shares. Stakool, Inc., is a development-stage company. The Company conducts its business operations through ECRV Hanover LeaseCo, LLC (Hanover), ECRV Clinton LeaseCo, LLC (Clinton), and ECRV FM LeaseCo, LCC (Absecon).
Why Should Investors Buy STKO After The Recent Gain? Just Go Here and Find Out
About LeadingStockAlerts:
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
Disclaimer:
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/